Surrogate viruses for use in disinfectant efficacy tests to justify claims against Monkeypox

TGA

For sponsors and manufacturers wishing to make label claims of efficacy against Monkeypox for products that are either hard surface disinfectants or disinfectants that are medical devices, the following surrogate viruses can be used in testing to substantiate such a claim:

  • Vaccinia virus

At this point, no other surrogate viruses have been identified.

/Public Release. This material from the originating organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.